Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pinaverium Bromide Preventing Post Extracorporeal Shock Wave Lithotripsy Pancreatitis and Painful (PBPEP): a Single-center, Double-blind, Randomized, Placebo-controlled Trial.

NCT06936800 is registered in ClinicalTrials.gov with Yanqing Li as lead sponsor.

NCT NCT06936800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06936800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pinaverium Bromide Preventing Post Extracorporeal Shock Wave Lithotripsy Pancreatitis and Painful (PBPEP): a Single-center, Double-blind, Randomized, Placebo-controlled Trial.
Lead sponsor
Yanqing Li
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
March 1, 2025
Completion date
December 30, 2027
Enrollment
288 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pancreatitis, pancreatic duct stones